Studies in Sweden and Germany indicate that underweight women with multiple sclerosis who take the MS drug Gilenya (fingolimod) seem to be at increased risk for lymphopenia. The drug also poses a risk for patients who have low lymphocyte levels before they start drug treatment.
Lymphopenia (also known as lymphocytopenia) is a condition in which a person has a deficiency (penia) of lymphocytes, which are a subset of white blood cells (leukocytes). Lymphocytes, which can be T cells, B cells, or natural killer cells, play a crucial role in supporting immune system function.... Read More - http://www.ms-uk.org/gilenya
MS drug Gilenya may increase risk of lymphopenia
MS drug Gilenya may increase risk of lymphopenia
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 4487 Views
-
Last post by ElliotB
-
- 5 Replies
- 12774 Views
-
Last post by gibbledygook
-
- 0 Replies
- 2274 Views
-
Last post by NHE
-
- 6 Replies
- 6137 Views
-
Last post by ElliotB
-
- 0 Replies
- 1314 Views
-
Last post by NHE
-
- 0 Replies
- 3384 Views
-
Last post by NHE
-
- 1 Replies
- 1011 Views
-
Last post by NHE
-
- 11 Replies
- 3305 Views
-
Last post by NHE
-
- 1 Replies
- 1493 Views
-
Last post by NHE